2017 annual financial data
Galectin Therapeutics 2017 Operating margin
Galectin Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -16,247,000 USD and net income was -16,235,000 USD.
Operating cash flow was -15,892,000 USD.
Get free Galectin Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -16,247,000 USD
- Net income
- -16,235,000 USD
- Operating cash flow
- -15,892,000 USD